Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Stirrups

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
The Lancet. Oncology|January 22, 2019
Minimally invasive oesophagectomy for oesophageal cancerRobert Stirrups
The Lancet. Oncology|September 25, 2018
Atezolizumab for metastatic triple-negative breast cancerRobert Stirrups
The Lancet. Neurology|February 22, 2020
Sight reveals itselfRobert Stirrups
The Lancet. Neurology|January 25, 2025
Standing in Cushing's shadowRobert Stirrups
The Lancet. Oncology|April 3, 2018
Venetoclax plus rituximab for chronic lymphocytic leukaemiaRobert Stirrups
The Lancet. Neurology|June 4, 2023
To sleep, perchance to dreamRobert Stirrups
The Lancet. Neurology|April 20, 2026
Songs and stories, memory, and knowledgeRobert Stirrups
The Lancet. Neurology|May 13, 2026
Social connection: a fundamental need for good healthRobert Stirrups
The Lancet. Oncology|September 17, 2019
Metformin plus EGFR TKIs for lung adenocarcinomaRobert Stirrups
The Lancet. Oncology|October 8, 2019
Abemaciclib plus fulvestrant for breast cancerRobert Stirrups
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
The Lancet. Oncology|January 22, 2019
Minimally invasive oesophagectomy for oesophageal cancerRobert Stirrups
The Lancet. Oncology|September 25, 2018
Atezolizumab for metastatic triple-negative breast cancerRobert Stirrups
The Lancet. Neurology|February 22, 2020
Sight reveals itselfRobert Stirrups
The Lancet. Neurology|January 25, 2025
Standing in Cushing's shadowRobert Stirrups
The Lancet. Oncology|April 3, 2018
Venetoclax plus rituximab for chronic lymphocytic leukaemiaRobert Stirrups
The Lancet. Neurology|June 4, 2023
To sleep, perchance to dreamRobert Stirrups
The Lancet. Neurology|April 20, 2026
Songs and stories, memory, and knowledgeRobert Stirrups
The Lancet. Neurology|May 13, 2026
Social connection: a fundamental need for good healthRobert Stirrups
The Lancet. Oncology|September 17, 2019
Metformin plus EGFR TKIs for lung adenocarcinomaRobert Stirrups
The Lancet. Oncology|October 8, 2019
Abemaciclib plus fulvestrant for breast cancerRobert Stirrups
Pageof 5